UPDATE: Jefferies Raises PT on Pfizer on Attractive Valuation
April 10, 2013 at 12:12 PM EDT
In a report published Wednesday, Jefferies analyst Jeffrey Holford reiterated a Buy rating on Pfizer (NYSE: PFE ), and raised the price target from $31.00 to $33.00. In the report, Holford noted, “We remain positive on Pharmaceuticals and see valuation as attractive for most stocks. Our Top Pick in the